These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2391188)

  • 21. [The effect of intraperitoneal administration of OK-432 with recombinant interleukin-2 to patients with peritonitis carcinomatosa of recurrent gynecological cancer and changes in ascitic lymphocyte subsets].
    Kanaoka Y; Umesaki N
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):489-96. PubMed ID: 2056223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunotherapy of malignant lymphoma with interleukin-2 and sizofiran--a basic study on EL-4 lymphoma-transplanted mice].
    Hashimoto J
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Jul; 97(7):1235-49. PubMed ID: 8064508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
    Ishida N; Saito M; Nanjo M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432.
    Saito M; Nanjo M; Aonuma E; Noda T; Nakadate I; Ebina T; Ishida N
    Int J Cancer; 1984 Feb; 33(2):271-6. PubMed ID: 6420351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effects of a new interleukin-2 slow delivery system on methylcholanthrene-induced fibrosarcoma in mice.
    Fujiwara T; Sakagami K; Orita K
    J Cancer Res Clin Oncol; 1990; 116(2):141-8. PubMed ID: 2324156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective in vivo induction of lymphokine-activated killer (LAK) cells by pretreatment with a streptococcal preparation, OK-432.
    Shimoda K; Saito T; Kobayashi M; Nomoto K
    Biotherapy; 1992; 5(1):63-9. PubMed ID: 1389903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphokine-activated killer cells and aging in mice: significance for defining the precursor cell.
    Kawakami K; Bloom ET
    Mech Ageing Dev; 1987 Dec; 41(3):229-40. PubMed ID: 2892985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E; Maeda H
    Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T; Sato S; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy of OK-432 and recombinant interleukin 2 in the antitumor immunity induction and the cytotoxic T-lymphocyte generation.
    Ujiie T
    Jpn J Exp Med; 1990 Jun; 60(3):85-92. PubMed ID: 2214256
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
    Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
    Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
    Butler LD; Browne CP; Layman NK; Riedl P; Tang J; Marder P; DeLong D; Manetta J; Bobbitt L; Strnad J
    Cancer Res; 1988 Nov; 48(21):6081-9. PubMed ID: 3048654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4.
    Ahmed SU; Okamoto M; Oshikawa T; Tano T; Sasai A; Kan S; Hiroshima T; Ohue H; Moriya Y; Ryoma Y; Saito M; Sato M
    J Immunother; 2004; 27(6):432-41. PubMed ID: 15534487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.